Acme Universal Safezone 9 IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Sep 28 to Sep 30 2026
Price Band
₹65 - 71
Current GMP
₹101.0 (+42.25%)
Subscription
23.41 times
IPO Details
| IPO Date | 28 to 30 Sep, 2026 |
| Listed on | Tue, Oct 6, 2026 |
| Face Value | ₹ 10 per share |
| Price Band | ₹65 to ₹71 |
| Issue Price | ₹71 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 50,60,800 shares (agg. up to ₹ 36 Cr) |
| Reserved for Market Maker | 2,54,400 shares (agg. up to ₹ 2 Cr) JSK Securities & Services Pvt.Ltd. |
| Fresh Issue (Ex Market Maker) | 48,06,400 shares (agg. up to ₹ 34 Cr) |
| Net Offered to Public | 48,06,400 shares (agg. up to ₹ 34 Cr) |
| Share Holding Pre Issue | 1,40,32,620 shares |
| Share Holding Post Issue | 1,90,93,420 shares |
| BSE Script Code | 544964 |
| ISIN | INE1KUL01020 |
IPO Date
28 to 30 Sep, 2026
Listed on
Tue, Oct 6, 2026
Face Value
₹ 10 per share
Price Band
₹65 to ₹71
Issue Price
₹71 per share
Lot Size
1,600 Shares
Sale Type
Fresh capital only
Issue Type
Bookbuilding IPO
Listing At
BSE SME
Total Issue Size
50,60,800 shares (agg. up to ₹ 36 Cr)
Reserved for Market Maker
2,54,400 shares (agg. up to ₹ 2 Cr) JSK Securities & Services Pvt.Ltd.
Fresh Issue (Ex Market Maker)
48,06,400 shares (agg. up to ₹ 34 Cr)
Net Offered to Public
48,06,400 shares (agg. up to ₹ 34 Cr)
Share Holding Pre Issue
1,40,32,620 shares
Share Holding Post Issue
1,90,93,420 shares
BSE Script Code
544964
ISIN
INE1KUL01020
IPO Subscription Details
| Anchor | 1 |
| Market Maker | 1 |
| QIB (Ex Anchor) | 31.29 |
| NII*** | 31.98 |
| bNII (> ₹10L) | 39.48 |
| sNII (< ₹10L) | 16.99 |
| Individual Investors | 15.22 |
| Total ** | 23.41 |
Anchor
1
Market Maker
1
QIB (Ex Anchor)
31.29
NII***
31.98
bNII (> ₹10L)
39.48
sNII (< ₹10L)
16.99
Individual Investors
15.22
Total **
23.41
Day Wise Sub
| Day | QIB (Ex Anchor) | NII* | NII (> ₹10L) | NII (< ₹10L) | Individual Investors | Total |
|---|---|---|---|---|---|---|
| Sep 2 8 (Day 1) | 0.00 | 0.52 | 0.38 | 0.81 | 0.16 | 0.13 |
| Sep 2 9 (Day 2) | 0.00 | 1.14 | 0.93 | 1.56 | 0.39 | 0.44 |
| Sep 3 0 (Day 3) | 31.29 | 31.98 | 39.48 | 16.99 | 15.22 | 23.41 |
DaySep 2
8 (Day 1)
QIB (Ex Anchor)0.00
NII*0.52
NII (> ₹10L)0.38
NII (< ₹10L)0.81
Individual Investors0.16
Total0.13
DaySep 2
9 (Day 2)
QIB (Ex Anchor)0.00
NII*1.14
NII (> ₹10L)0.93
NII (< ₹10L)1.56
Individual Investors0.39
Total0.44
DaySep 3
0 (Day 3)
QIB (Ex Anchor)31.29
NII*31.98
NII (> ₹10L)39.48
NII (< ₹10L)16.99
Individual Investors15.22
Total23.41
Day Wise GMP
| GMP Date | IPO Price | GMP | Est. Listing Price |
|---|---|---|---|
| 06-10-2026 | 71 | 16 (22.54%) | 87 |
| 05-10-2026 | 71 | 15 (21.13%) | 86 |
| 04-10-2026 | 71 | 15 (21.13%) | 86 |
| 03-10-2026 | 71 | 13 (18.31%) | 84 |
| 02-10-2026 | 71 | 11 (15.49%) | 82 |
| 01-10-2026 | 71 | 11 (15.49%) | 82 |
| 30-09-2026 | 71 | 10 (14.08%) | 81 |
GMP Date06-10-2026
IPO Price71
GMP16 (22.54%)
Est. Listing Price87
GMP Date05-10-2026
IPO Price71
GMP15 (21.13%)
Est. Listing Price86
GMP Date04-10-2026
IPO Price71
GMP15 (21.13%)
Est. Listing Price86
GMP Date03-10-2026
IPO Price71
GMP13 (18.31%)
Est. Listing Price84
GMP Date02-10-2026
IPO Price71
GMP11 (15.49%)
Est. Listing Price82
GMP Date01-10-2026
IPO Price71
GMP11 (15.49%)
Est. Listing Price82
GMP Date30-09-2026
IPO Price71
GMP10 (14.08%)
Est. Listing Price81
IPO Important Dates
| IPO Open | Mon, Sep 28, 2026 |
| IPO Close | Wed, Sep 30, 2026 |
| Allotment | Thu, Oct 1, 2026 |
| Refund | Mon, Oct 5, 2026 |
| Credit of Shares | Mon, Oct 5, 2026 |
| Listing | Tue, Oct 6, 2026 |
IPO Open
Mon, Sep 28, 2026
IPO Close
Wed, Sep 30, 2026
Allotment
Thu, Oct 1, 2026
Refund
Mon, Oct 5, 2026
Credit of Shares
Mon, Oct 5, 2026
Listing
Tue, Oct 6, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (IND) (Min) | 2 | 3200 | ₹2,27,200 |
| Individual investors (IND) (Max) | 2 | 3200 | ₹2,27,200 |
| S-HNI (Min) | 3 | 4800 | ₹3,40,800 |
| S-HNI (Max) | 8 | 12800 | ₹9,08,800 |
| B-HNI (Min) | 9 | 14400 | ₹10,22,400 |
ApplicationIndividual investors (IND) (Min)
Lots2
Shares3200
Amount₹2,27,200
ApplicationIndividual investors (IND) (Max)
Lots2
Shares3200
Amount₹2,27,200
ApplicationS-HNI (Min)
Lots3
Shares4800
Amount₹3,40,800
ApplicationS-HNI (Max)
Lots8
Shares12800
Amount₹9,08,800
ApplicationB-HNI (Min)
Lots9
Shares14400
Amount₹10,22,400
Financial Information
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 146.72 | 133.70 | 119.07 |
| Total Income | 211.16 | 191.31 | 181.67 |
| Profit After Tax | 5.86 | 0.80 | 7.56 |
| EBITDA | 15.15 | 9.85 | 14.55 |
| NET Worth | 52.77 | 46.91 | 41.96 |
| Reserves and Surplus | 38.74 | 42.23 | 37.50 |
| Total Borrowing | 58.05 | 49.65 | 44.51 |
Period EndedAssets
31 Mar 2026146.72
31 Mar 2025133.70
31 Mar 2024119.07
Period EndedTotal Income
31 Mar 2026211.16
31 Mar 2025191.31
31 Mar 2024181.67
Period EndedProfit After Tax
31 Mar 20265.86
31 Mar 20250.80
31 Mar 20247.56
Period EndedEBITDA
31 Mar 202615.15
31 Mar 20259.85
31 Mar 202414.55
Period EndedNET Worth
31 Mar 202652.77
31 Mar 202546.91
31 Mar 202441.96
Period EndedReserves and Surplus
31 Mar 202638.74
31 Mar 202542.23
31 Mar 202437.50
Period EndedTotal Borrowing
31 Mar 202658.05
31 Mar 202549.65
31 Mar 202444.51
Key Performance Indicator
| ROCE | 5.54% |
| Debt/Equity | 1.10 |
| RoNW | 11.75% |
| PAT Margin | 2.84% |
| EBITDA Margin | 7.36% |
| NAV | 37.60 |
| P/B (x) | 1.89 |
ROCE
5.54%
Debt/Equity
1.10
RoNW
11.75%
PAT Margin
2.84%
EBITDA Margin
7.36%
NAV
37.60
P/B (x)
1.89
IPO Reservation
| QIB | 23,98,400 |
| − Anchor Investor | 14,38,400 |
| − QIB (Ex. Anchor) | 9,60,000 |
| NII (HNI) | 7,24,800 |
| − bNII > ₹10L | 4,83,200 |
| − sNII < ₹10L | 2,41,600 |
| Retail | 16,83,200 |
| Market Maker | 2,54,400 |
| Total | 50,60,800 |
QIB
23,98,400
− Anchor Investor
14,38,400
− QIB (Ex. Anchor)
9,60,000
NII (HNI)
7,24,800
− bNII > ₹10L
4,83,200
− sNII < ₹10L
2,41,600
Retail
16,83,200
Market Maker
2,54,400
Total
50,60,800
Information about company
Incorporated in November 2016, Acme Universal Safezone 9 Limited operates in the Personal Protective Equipment (PPE) segment, focusing on industrial safety footwear for sectors including construction, oil and gas, mining, heavy engineering, automotive, pharmaceuticals, chemical processing, foundry and power generation. It offers 15 product lines across EVA-rubber, Nitrile Rubber and PVC sole types, providing protection against impact, compression, penetration, electrical shock, static electricity, heat and fire, chemicals and slipping.
The Company operates four manufacturing facilities across Madhya Pradesh and Uttar Pradesh. It uses ICad3D technology for product design and visualisation and SAP S/4 HANA for enterprise resource planning across finance, operations and logistics. Its products are distributed through direct institutional sales, regional distributors and dealers, and digital and e-commerce channels, supported by warehousing at more than 40 locations across India. The Company also exports to markets including the UAE, Bahrain, Saudi Arabia, Nigeria, Israel, the Netherlands, Hong Kong, Cameroon and Mauritius.
The Company manufactures products compliant with applicable IS 15298, EN ISO 20345, ASTM F2413 and SEDEX SMETA standards, depending on the product variant and export destination. It also develops customised products based on customer requirements. For FY2026, the Company reported revenue from operations of ₹20,590.31 lakhs, EBITDA of ₹1,515.19 lakhs and PAT of ₹585.73 lakhs.
As of March 31, 2026, the Company had a total manpower strength of 1,073 employees across finance, HR, IT, marketing, operations and sales.
Competitive Strengths
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
#: Issue Objects
1: Funding capital expenditure requirements for the installation of solar power plant
2: Funding capital expenditure requirements towards installation of additional machinery
3: Funding incremental working capital requirements of the Company
4: Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes
: Total
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App